Topics and Expertise: prostate cancer

Marcus Ferrone, PharmD, JD, a faculty member in the Department of Clinical Pharmacy, has been named the California Pharmacists Association (CPhA) 2015 Innovative Pharmacist of the Year.

Magnetic resonance imaging (MRI), used with a novel pyruvate chemical compound that is specially labeled to be read by the MRI machine, is being applied for the first time in humans to study the aggressiveness of prostate cancer in patients and the success of prostate cancer therapies.